
Liminatus Pharma, Inc. Class A Common Stock Share Price
NASDAQ: LIMN
Live Liminatus Pharma, Inc. Class A Common Stock Share Price Chart
O H L
Liminatus Pharma, Inc. Class A Common Stock Performance Overview
Days Range
▼
$3.41Low
$3.41High
Markets Today
| Previous Close | $3.39 |
|---|---|
| Open | $3.41 |
| Volume | 8,873 |
| Day's Range | $3.41 - $3.41 |
| 52W Range | NA |
| Market Cap | $4.47 M |
Historical Performance
| 1M Returns | -47.85 |
|---|---|
| 3M Returns | -43.12 |
| 6M Returns | -68.05 |
| 1Y Returns | -94.74 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Liminatus Pharma, Inc. Class A Common Stock Fundamentals
| Market Cap | $4.47 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
| Market Cap | $4.47 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
Liminatus Pharma, Inc. Class A Common Stock Return Calculator
The Liminatus Pharma, Inc. Class A Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Liminatus Pharma, Inc. Class A Common Stock
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The company is developing a next generation CD47 immune checkpoint inhibitor that enables cancer cells to evade detection by the immune system. Anti-CD47 monoclonal antibodies generally induce anemia and thrombocytopenia due to their binding to red blood cells and platelets. The Liminatus CD47 mAb has shown to preferentially bind to immune cells, but not to red blood cells and platelets and does not induce hemolysis. The clinical candidate is currently in the late preclinical stage.
Popular Stocks
FAQs
What is the share price of Liminatus Pharma, Inc. Class A Common Stock today?
Liminatus Pharma, Inc. Class A Common Stock (LIMN) share price as of September 18, 2026 is $3.37. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Liminatus Pharma, Inc. Class A Common Stock?
Yes, Indian Investors can invest in the Liminatus Pharma, Inc. Class A Common Stock (LIMN) Share by opening an international trading account with Angel One.
How can I purchase Liminatus Pharma, Inc. Class A Common Stock shares in India?
Purchasing Liminatus Pharma, Inc. Class A Common Stock (LIMN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Liminatus Pharma, Inc. Class A Common Stock (LIMN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Liminatus Pharma, Inc. Class A Common Stock?
Yes, you can purchase fractional shares of Liminatus Pharma, Inc. Class A Common Stock (LIMN) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Liminatus Pharma, Inc. Class A Common Stock?
The market capitalization of Liminatus Pharma, Inc. Class A Common Stock on September 18, 2026, is $4.47 M.
In which sector Liminatus Pharma, Inc. Class A Common Stock belongs?
Liminatus Pharma, Inc. Class A Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in Liminatus Pharma, Inc. Class A Common Stock stocks?
In order to invest in Liminatus Pharma, Inc. Class A Common Stock (LIMN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
